Kais A Rona1, Jessica Reynolds1, Katrin Schwameis1, Joerg Zehetner1,2, Kamran Samakar1,2, Paul Oh1, David Vong1, Kulmeet Sandhu1,2, Namir Katkhouda1,2, Nikolai Bildzukewicz1,2, John C Lipham3,4,5. 1. Keck School of Medicine of USC, Los Angeles, CA, USA. 2. Department of General Surgery, Keck Hospital of USC, 1510 San Pablo St., HCC Suite 514, Los Angeles, CA, 90033, USA. 3. Keck School of Medicine of USC, Los Angeles, CA, USA. john.lipham@med.usc.edu. 4. Department of General Surgery, Keck Hospital of USC, 1510 San Pablo St., HCC Suite 514, Los Angeles, CA, 90033, USA. john.lipham@med.usc.edu. 5. James and Pamela Muzzy Endowed Chair in Gastrointestinal Cancer, Hoag Memorial Hospital Presbyterian, Newport Beach, CA, USA. john.lipham@med.usc.edu.
Abstract
BACKGROUND: Magnetic sphincter augmentation (MSA) has demonstrated long-term safety and efficacy in the treatment of patients with gastroesophageal reflux (GERD), but its efficacy in patients with large hiatal hernias has yet to be proven. The aim of our study was to assess outcomes of MSA in patients with hiatal hernias ≥3 cm. METHODS: We retrospectively reviewed all patients who underwent MSA at our institutions over a 6-year period. Information obtained consisted of patient demographics, symptoms of GERD, preoperative GERD Health-Related Quality-of-Life (HRQL) scores, perioperative details, and implantation of the MSA device. Primary endpoints included postoperative GERD-HRQL scores, proton-pump inhibitor (PPI) use, symptom change, and procedure-related complications. A large hiatal hernia was defined as a hernia measuring ≥3 cm by intraoperative measurement. RESULTS: A total of 192 patients were reviewed. Median follow-up was 20 months (3-75 months). Mean GERD-HRQL scores in the overall population before and after MSA were 18.9 and 5.0, respectively (p < 0.001). In the majority of patients symptoms improved or resolved (N = 177, p < 0.001). Fifty-two patients (27.0 %) had a hiatal hernia ≥3 cm (range 3-7 cm). Their mean GERD-HRQL score decreased from 20.5 to 3.6 (p < 0.001) following MSA. When compared to patients with smaller hernias, patients with large hiatal hernias had decreased postoperative PPI requirement (9.6 vs. 26.6 %, p = 0.011) and lower mean postoperative GERD-HRQL scores (3.6 vs. 5.6, p = 0.027). The percent of patients requiring postoperative intervention for dysphagia was similar (13.5 vs. 17.9 %, p = 0.522), as was the incidence of symptom resolution or improvement (98.1 vs. 91.3 %, p = 0.118). CONCLUSION: MSA in patients with large hiatal hernias demonstrates decreased postoperative PPI requirement and mean GERD-HRQL scores compared to patients with smaller hernias. The incidence of symptom resolution or improvement and the percentage of patients requiring intervention for dysphagia are similar. Short-term outcomes of MSA are encouraging in patients with gastroesophageal reflux disease and large hiatal hernias.
BACKGROUND: Magnetic sphincter augmentation (MSA) has demonstrated long-term safety and efficacy in the treatment of patients with gastroesophageal reflux (GERD), but its efficacy in patients with large hiatal hernias has yet to be proven. The aim of our study was to assess outcomes of MSA in patients with hiatal hernias ≥3 cm. METHODS: We retrospectively reviewed all patients who underwent MSA at our institutions over a 6-year period. Information obtained consisted of patient demographics, symptoms of GERD, preoperative GERD Health-Related Quality-of-Life (HRQL) scores, perioperative details, and implantation of the MSA device. Primary endpoints included postoperative GERD-HRQL scores, proton-pump inhibitor (PPI) use, symptom change, and procedure-related complications. A large hiatal hernia was defined as a hernia measuring ≥3 cm by intraoperative measurement. RESULTS: A total of 192 patients were reviewed. Median follow-up was 20 months (3-75 months). Mean GERD-HRQL scores in the overall population before and after MSA were 18.9 and 5.0, respectively (p < 0.001). In the majority of patients symptoms improved or resolved (N = 177, p < 0.001). Fifty-two patients (27.0 %) had a hiatal hernia ≥3 cm (range 3-7 cm). Their mean GERD-HRQL score decreased from 20.5 to 3.6 (p < 0.001) following MSA. When compared to patients with smaller hernias, patients with large hiatal hernias had decreased postoperative PPI requirement (9.6 vs. 26.6 %, p = 0.011) and lower mean postoperative GERD-HRQL scores (3.6 vs. 5.6, p = 0.027). The percent of patients requiring postoperative intervention for dysphagia was similar (13.5 vs. 17.9 %, p = 0.522), as was the incidence of symptom resolution or improvement (98.1 vs. 91.3 %, p = 0.118). CONCLUSION: MSA in patients with large hiatal hernias demonstrates decreased postoperative PPI requirement and mean GERD-HRQL scores compared to patients with smaller hernias. The incidence of symptom resolution or improvement and the percentage of patients requiring intervention for dysphagia are similar. Short-term outcomes of MSA are encouraging in patients with gastroesophageal reflux disease and large hiatal hernias.
Entities:
Keywords:
GERD; Hiatal hernia; LINX; MSA; Magnetic sphincter augmentation
Authors: Karl Hermann Fuchs; Benjamin Babic; Wolfram Breithaupt; Bernard Dallemagne; Abe Fingerhut; Edgar Furnee; Frank Granderath; Peter Horvath; Peter Kardos; Rudolph Pointner; Edoardo Savarino; Maud Van Herwaarden-Lindeboom; Giovanni Zaninotto Journal: Surg Endosc Date: 2014-05-02 Impact factor: 4.584
Authors: S J Sontag; D G Kogut; R Fleischmann; D R Campbell; J Richter; M Robinson; M McFarland; S Sabesin; G A Lehman; D Castell Journal: Am J Gastroenterol Date: 1997-03 Impact factor: 10.864
Authors: Jessica L Reynolds; Joerg Zehetner; Phil Wu; Shawn Shah; Nikolai Bildzukewicz; John C Lipham Journal: J Am Coll Surg Date: 2015-03-05 Impact factor: 6.113
Authors: Brian E Louie; Alexander S Farivar; Dale Shultz; Christina Brennan; Eric Vallières; Ralph W Aye Journal: Ann Thorac Surg Date: 2014-06-21 Impact factor: 4.330
Authors: Brian E Louie; Seema Kapur; Maurice Blitz; Alexander S Farivar; Eric Vallières; Ralph W Aye Journal: J Gastrointest Surg Date: 2012-11-27 Impact factor: 3.452
Authors: Beat P Müller-Stich; Georg R Linke; Jonas Senft; Verena Achtstätter; Philip C Müller; Markus K Diener; Rene Warschkow; Francesco Marra; Bruno M Schmied; Jan Borovicka; Lars Fischer; Andreas Zerz; Carsten N Gutt; Markus W Büchler Journal: Ann Surg Date: 2015-11 Impact factor: 12.969
Authors: James M Tatum; Evan Alicuben; Nikolai Bildzukewicz; Kamran Samakar; Caitlin C Houghton; John C Lipham Journal: Surg Endosc Date: 2018-07-13 Impact factor: 4.584
Authors: Heather F Warren; Lisa M Brown; Matias Mihura; Alexander S Farivar; Ralph W Aye; Brian E Louie Journal: Surg Endosc Date: 2017-06-29 Impact factor: 4.584
Authors: Philip O Katz; Kerry B Dunbar; Felice H Schnoll-Sussman; Katarina B Greer; Rena Yadlapati; Stuart Jon Spechler Journal: Am J Gastroenterol Date: 2022-01-01 Impact factor: 10.864
Authors: Evan T Alicuben; James M Tatum; Nikolai Bildzukewicz; Kamran Samakar; Jamil S Samaan; Einav N Silverstein; Kulmeet Sandhu; Caitlin C Houghton; John C Lipham Journal: Surg Endosc Date: 2018-07-25 Impact factor: 4.584
Authors: Kais A Rona; James M Tatum; Joerg Zehetner; Katrin Schwameis; Carol Chow; Kamran Samakar; Adrian Dobrowolsky; Caitlin C Houghton; Nikolai Bildzukewicz; John C Lipham Journal: Surg Endosc Date: 2018-01-16 Impact factor: 4.584
Authors: James M Tatum; Evan Alicuben; Nikolai Bildzukewicz; Kamran Samakar; Caitlin C Houghton; John C Lipham Journal: Surg Endosc Date: 2018-11-01 Impact factor: 4.584
Authors: Michael Weitzendorfer; Gernot Köhler; Stavros A Antoniou; Leo Pallwein-Prettner; Lisa Manzenreiter; Philipp Schredl; Klaus Emmanuel; Oliver Owen Koch Journal: Eur Surg Date: 2017-09-19 Impact factor: 0.953